Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Takagi · SciRah

Researcher profile · Semantic Scholar

T. Takagi

Share profile

T. Takagi — researcher profile on SciRah

h-index: 32
Works: 420
Citations: 5,801

Most-cited papers

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
R. Motzer, C. Porta, Masatoshi Eto, T. Powles +32 more
2024Journal of Clinical Oncology134 citations Open access
Semantic Scholar
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
Viktor Grünwald, T. Powles, M. Eto, E. Kopyltsov +17 more
2023Frontiers in Oncology42 citations Open access
Semantic Scholar
Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial
V. Grünwald, R. McKay, T. Buchler, Masatoshi Eto +17 more
2024International Journal of Cancer21 citations Open access
Semantic Scholar
Comparison of Outcomes Between Therapeutic Combinations Based on Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitor Monotherapy for First-Line Therapy of Patients with Advanced Renal Cell Carcinoma Outside of Clinical Trials: A Real-World Retrospective Multi-Institutional Study
Hiroki Ishihara, Yukiaki Nemoto, Kazutaka Nakamura, H. Tachibana +9 more
2023Targeted oncology19 citations
Semantic Scholar
First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the effectiveness using real-world data
Hiroki Ishihara, K. Omae, Yukiaki Nemoto, Ryo Ishiyama +11 more
2024International Journal of Clinical Oncology16 citations
Semantic Scholar
A single‐center retrospective comparative analysis of urinary continence in robotic prostatectomy with a combination of umbilical ligament preservation and Hood technique
H. Shimmura, Taro Banno, Kazutaka Nakamura, A. Murayama +7 more
2023International journal of urology13 citations
Semantic Scholar
Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab
Kazutaka Nakamura, Yudai Ishiyama, Yukiaki Nemoto, Hiroki Ishihara +9 more
2023International Journal of Clinical Oncology8 citations
Semantic Scholar
Pregnancy Complications and Impact on Kidney Allograft After Kidney Transplantation in IgA Nephropathy
R. Oki, Kohei Unagami, J. Kakogawa, H. Beppu +10 more
2023Transplant International8 citations Open access
Semantic Scholar
Sex differences in immunotherapy outcomes and tumor-infiltrating immune cell profiles in patients with advanced renal cell carcinoma
Hiroki Ishihara, H. Fukuda, Yukihiro Mizoguchi, M. Yamashita +13 more
2025Cancer Immunology and Immunotherapy7 citations Open access
Semantic Scholar
Comparison of real-world outcomes between nivolumab plus ipilimumab and lenvatinib plus pembrolizumab or nivolumab plus cabozantinib combination therapies for previously untreated advanced renal cell carcinoma.
Hiroki Ishihara, K. Omae, Yukiaki Nemoto, Shinsuke Mizoguchi +9 more
2025Urologic oncology7 citations
Semantic Scholar
Impact of body composition on outcomes of immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma.
Hiroki Ishihara, K. Nishimura, Takashi Ikeda, H. Fukuda +4 more
2024Urologic oncology7 citations
Semantic Scholar
Efficacy of robot-assisted partial nephrectomy compared to conventional laparoscopic partial nephrectomy for completely endophytic renal tumor: a multicenter, prospective study
Nobuyuki Hinata, Sae Murakami, Y. Nakano, Isao Hara +15 more
2024International Journal of Clinical Oncology7 citations Open access
Semantic Scholar
Impact of sex on prognosis in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors.
Yukiaki Nemoto, Hiroki Ishihara, Kazutaka Nakamura, H. Tachibana +8 more
2023Japanese Journal of Clinical Oncology7 citations
Semantic Scholar
Prognostic Value of the Lung Immune Prognostic Index on Recurrence after Radical Surgery for High-Risk Renal Cell Carcinoma
Yudai Ishiyama, T. Kondo, K. Yoshida, J. Iizuka +1 more
2024Cancers6 citations Open access
Semantic Scholar
Real-world efficacy and safety of cabozantinib following immune checkpoint inhibitor failure in Japanese patients with advanced renal cell carcinoma.
Hiroki Ishihara, Yukiaki Nemoto, H. Tachibana, H. Fukuda +6 more
2023Japanese Journal of Clinical Oncology6 citations
Semantic Scholar
Predictive factors and oncological outcomes of pathological T3a upstaging in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
Ryo Ishiyama, K. Omae, T. Kondo, J. Iizuka +6 more
2023Japanese Journal of Clinical Oncology6 citations
Semantic Scholar
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial
S. Rha, T. Choueiri, V. Matveev, A. Alyasova +13 more
2023International Journal of Cancer6 citations Open access
Semantic Scholar
Long-term real-world outcomes of nivolumab plus ipilimumab for advanced renal cell carcinoma: a minimum of 4-years follow-up study.
Hiroki Ishihara, K. Nishimura, Yukiaki Nemoto, Shinsuke Mizoguchi +9 more
2025Japanese Journal of Clinical Oncology5 citations
Semantic Scholar
Robot-assisted Partial Nephrectomy With Selective Artery Clamping for Renal Cell Carcinoma in Horseshoe Kidney
Y. Kobari, K. Yoshida, Takanori Endo, Ryohei Minoda +5 more
2024In Vivo5 citations Open access
Semantic Scholar
Surgical and functional outcomes of repeat robot‐assisted laparoscopic partial nephrectomy compared with repeat open partial nephrectomy
K. Yoshida, Nao Oida, T. Kondo, Y. Kobari +6 more
2023International journal of urology5 citations
Semantic Scholar
Outcomes of Enfortumab Vedotin Treatment in Patients Ineligible for the EV-301 Trial
Kazutaka Nakamura, Y. Kobari, Yudai Ishiyama, Hanae Kondo +11 more
2025In Vivo4 citations Open access
Semantic Scholar
Prognostic Impact of the Administration of Antibiotics and Proton Pump Inhibitors in Immune Checkpoint Inhibitor Combination Therapy for Advanced Renal Cell Carcinoma.
N. Katsurayama, Hiroki Ishihara, Ryo Ishiyama, Yukiaki Nemoto +10 more
2024Cancer Diagnosis & Prognosis4 citations Open access
Semantic Scholar
Predicting Recurrence After Radical Surgery for High-Risk Renal Cell Carcinoma: Development and Internal Validation of the “TOWARDS” Score
Yudai Ishiyama, K. Omae, T. Kondo, K. Yoshida +2 more
2024Annals of Surgical Oncology4 citations
Semantic Scholar
Higher risk of intraoperative bleeding in right‐sided renal tumors compared to left‐sided tumors in robot‐assisted partial nephrectomy
H. Tachibana, Y. Kobari, H. Fukuda, Kazuhiko Yoshida +3 more
2023Asian Journal of Endoscopic Surgery4 citations Open access
Semantic Scholar
Long-time Survival of a Renal Transplant Recipient With Metastatic Mucinous Tubular and Spindle Cell Carcinoma: A Case Report
Y. Kobari, Kazuhiko Yoshida, Ryohei Minoda, H. Fukuda +6 more
2023In Vivo4 citations Open access
Semantic Scholar
Machine learning-based prediction of postoperative mortality in emergency colorectal surgery: A retrospective, multicenter cohort study using Tokushukai medical database
Shota Akabane, Katsunori Miyake, Masao Iwagami, K. Tanabe +1 more
2023Heliyon4 citations Open access
Semantic Scholar
Clinicopathological Analyses of Chronic Renal Allograft Arteriopathy after Kidney Transplantation
T. Shimizu, K. Omoto, M. Inui, T. Nozaki +2 more
2023Nephron4 citations
Semantic Scholar
Midterm Outcomes of Combination Therapy With Immune Checkpoint Inhibitors and VEGFR‐TKIs in Real‐World Patients With Advanced Renal Cell Carcinoma
Hiroki Ishihara, N. Katsurayama, Yukiaki Nemoto, Shinsuke Mizoguchi +8 more
2026International journal of urology3 citations Open access
Semantic Scholar
Extended Follow‐Up of Robot‐Assisted Partial Nephrectomy for Renal Hilar Tumor: A Prospective Multi‐Institutional Study (ROBOHIT Trial)
J. Teishima, R. Shiroki, T. Takagi, Masatoshi Eto +18 more
2025International journal of urology3 citations
Semantic Scholar
Release of apoptosis inhibitor of macrophage (AIM) from pentameric IgM in serum predicts prognosis after hemodialysis initiation
Keisuke Yasuda, Akemi Nishijima, Tomoko Inoue, T. Takagi +4 more
2025Communications Medicine3 citations Open access
Semantic Scholar
Safety of Enfortumab Vedotin Plus Pembrolizumab in Hemodialysis Patients With Metastatic Urothelial Carcinoma: Case Report
T. Mizuno, Y. Kobari, Haruka Ito, Maki Yoshino +10 more
2025Cancer Diagnosis & Prognosis3 citations Open access
Semantic Scholar
Efficacy and safety of nivolumab plus cabozantinib in octogenarian patients with advanced renal cell carcinoma
Yukiaki Nemoto, Takanori Endo, Hogara Segawa, Kazutaka Nakamura +6 more
2025International Urology and Nephrology2 citations Open access
Semantic Scholar
Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan
Y. Kobari, J. Iizuka, Hanae Kondo, Makiko Ichioka +11 more
2025Anticancer Research2 citations
Semantic Scholar
Impact of starting dose of tyrosine kinase inhibitors on outcomes following combination therapy of immune checkpoint inhibitors with tyrosine kinase inhibitors for previously untreated advanced renal cell carcinoma.
Hiroki Ishihara, K. Nishimura, Yukiaki Nemoto, Shinsuke Mizoguchi +8 more
2025Japanese Journal of Clinical Oncology2 citations
Semantic Scholar
Association Between Kidney Function and Outcomes Following Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Carcinoma.
Hiroki Ishihara, Yukiaki Nemoto, H. Tachibana, Takashi Ikeda +8 more
2024Clinical Genitourinary Cancer2 citations
Semantic Scholar
Survival Impact of Glucocorticoid Administration for Adverse Events During Immune Checkpoint Inhibitor Combination Therapy in Patients with Previously Untreated Advanced Renal Cell Carcinoma
Maki Yoshino, Hiroki Ishihara, Yukiaki Nemoto, Shinsuke Mizoguchi +9 more
2024Targeted oncology2 citations
Semantic Scholar
Changes in outcome of patients with advanced non-clear cell renal cell carcinoma from the tyrosine kinase inhibitor era to the immuno-oncology era
Hiroki Ishihara, Yukiaki Nemoto, Shinsuke Mizoguchi, K. Nishimura +8 more
2024International Journal of Clinical Oncology2 citations
Semantic Scholar
Impact of tumor dissecting technique on trifecta achievement in patients requiring extended warm ischemia during robot-assisted partial nephrectomy
Yudai Ishiyama, T. Kondo, K. Yoshida, J. Iizuka +1 more
2024World journal of urology2 citations
Semantic Scholar
Comparative analysis of dual immune checkpoint inhibitor combination therapy versus immune checkpoint inhibitor plus tyrosine kinase inhibitor combination therapy for renal cell carcinoma with inferior vena cava tumor thrombosis
K. Yoshida, Naoki Nagasaka, T. Kondo, Y. Kobari +5 more
2024International Journal of Clinical Oncology2 citations
Semantic Scholar
Efficacy of Combined Pembrolizumab and Pelvic Radiotherapy for Bladder Cancer With Rectal Metastases
Chika Nagahisa, J. Iizuka, Y. Kobari, Ryohei Minoda +6 more
2023In Vivo2 citations Open access
Semantic Scholar
Editorial Comment on Disease‐free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: A retrospective analysis of Surveillance, Epidemiology and End Results‐Medicare data
Hiroki Ishihara, T. Takagi
2023International journal of urology2 citations
Semantic Scholar
Renal cell carcinoma outcomes in end‐stage renal disease: A 40‐year study from two Japanese institutions
Hiroki Ishihara, Takashi Ikeda, H. Fukuda, Kazuhiko Yoshida +5 more
2023International journal of urology2 citations Open access
Semantic Scholar
Clinicopathological differences in focal segmental glomerulosclerosis depending on the accompanying pathophysiological conditions in renal allografts
S. Taneda, Kazuho Honda, Junki Koike, Naoko Ito +3 more
2023Virchows Archiv2 citations Open access
Semantic Scholar
Case Report: Suspected Hyperacute Rejection During Living Kidney Transplantation.
T. Shimizu, S. Iida, K. Omoto, M. Inui +4 more
2023Transplantation Proceedings2 citations
Semantic Scholar
Anti‐Melanoma Differentiation‐Associated Gene 5 Antibody‐Positive Interstitial Lung Disease, Induced by Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Carcinoma
A. Saito, Hiroki Ishihara, Hanae Kondo, T. Takagi +1 more
2026IJU Case Reports1 citations Open access
Semantic Scholar
Non-clear-cell renal cell carcinoma has an immune cold phenotype that impacts response to immune checkpoint inhibitors.
Hiroki Ishihara, Yu-Yu Liu, Riu Yamashita, Hironori Fukuda +17 more
2026Molecular Cancer Research1 citations
Semantic Scholar
Real-world outcomes of third-line systemic therapy after immune checkpoint inhibitor combinations and subsequent VEGFR-TKIs in advanced renal cell carcinoma.
Hiroki Ishihara, K. Nishimura, Yukiaki Nemoto, Shinsuke Mizoguchi +8 more
2026Japanese Journal of Clinical Oncology1 citations
Semantic Scholar
Effect of age on treatment outcomes of first‐line immune checkpoint inhibitor combination therapy for previously untreated advanced renal cell carcinoma
Hiroki Ishihara, K. Nishimura, Yukiaki Nemoto, Shinsuke Mizoguchi +8 more
2025Geriatrics & Gerontology International1 citations
Semantic Scholar
Genome-wide transcriptome and DNA methylome profiling of acquired cystic disease-associated renal cell carcinoma.
Hiroki Ishihara, Riu Yamashita, Ryo Ishiyama, Takashi Ikeda +7 more
2025Pathology (Sydney)1 citations
Semantic Scholar
Treatment Profile of First‐Line Immune Checkpoint Inhibitor Combination Therapy for Advanced Renal Cell Carcinoma in Patients With End‐Stage Renal Disease on Dialysis
Hiroki Ishihara, Yukiaki Nemoto, Shinsuke Mizoguchi, K. Yoshida +2 more
2025International journal of urology1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Iizuka×34
Invite
J. Iizuka — researcher profile on SciRah
T. Kondo×33
Invite
T. Kondo — researcher profile on SciRah
H. Fukuda×28
Invite
H. Fukuda — researcher profile on SciRah
Hiroki Ishihara×26
Invite
Hiroki Ishihara — researcher profile on SciRah

×25

Invite

K. Yoshida — researcher profile on SciRah

Yukiaki Nemoto×21

Invite

Yukiaki Nemoto — researcher profile on SciRah

Y. Hashimoto×19

Invite

Y. Hashimoto — researcher profile on SciRah

H. Shimmura×16

Invite

H. Shimmura — researcher profile on SciRah

Shinsuke Mizoguchi×13

Invite

Shinsuke Mizoguchi — researcher profile on SciRah

Takashi Ikeda×10

Invite

Takashi Ikeda — researcher profile on SciRah

Invite

Y. Kobari — researcher profile on SciRah

T. Nakayama×10

Invite

T. Nakayama — researcher profile on SciRah